title: Interdependence of skeletal sclerosis and elevated circulating levels of 1,25-dihydroxyvitamin D in osteopetrotic (op and tl) rats.
abstract: Osteopetrosis describes a heterogeneous group of inherited, metabolic bone disorders characterized by reduced bone resorption which coexists with elevated circulating levels of 1,25-dihydroxyvitamin D [1,25(OH)2D]. To determine whether or not skeletal sclerosis and high concentrations of 1,25(OH)2D are interdependent, this study used two distinct, nonallelic osteopetrotic mutations in the rat, osteopetrosis (op) and toothless (tl). The op rat is a mutation in which skeletal sclerosis can be cured (mutant) or induced (normal) following the transfer of normal or mutant osteoclast progenitors, respectively. Although these procedures are ineffective in rats of tl stock, infusions of pharmacological doses of macrophage colony-stimulating factor (CSF-1) can stimulate bone resorption and eliminate most of the excess skeletal matrix in tl mutants. This study examined the effects of cure/induction in neonatal mutant/normal rats of op stock and CSF-1 infusions in mutant rats of tl stock on skeletal (bone resorption) and serum [1,25(OH)2D] parameters as a function of time after treatment. Osteopetrotic mutants transplanted (cured) with normal spleen cells demonstrated cellular changes in osteoclast phenotype within 2-3 days followed by histologic and radiographic evidence for increased bone resorption that culminated in a normal appearance of the skeleton by 4 weeks. The markedly elevated serum levels of 1,25(OH)2D observed in untreated mutants fell significantly in transplanted mutants by the end of the first week and were similar to those in normal littermates at 3 and 4 weeks. Normal littermates transplanted (induced) with mutant spleen cells showed a progressive increase in skeletal sclerosis paralleled by significant increases in circulating levels of 1,25(OH)2D.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Department of Anatomy and Cell Biology, Temple University School of Medicine, Philadelphia, PA 19140.
authors.forename: S N
authors.initials: SN
authors.lastname: Popoff
authors.forename: L K
authors.initials: LK
authors.lastname: Osier
authors.forename: J E
authors.initials: JE
authors.lastname: Zerwekh
authors.forename: S C
authors.initials: SC
authors.lastname: Marks
mesh_terms: D000704:Analysis of Variance; D000818:Animals; D001862:Bone Resorption / Q000378:metabolism; D001842:Bone and Bones / Q000473:pathology*; D002117:Calcitriol / Q000097:blood*; D002452:Cell Count; D002470:Cell Survival / Q000502:physiology; D004195:Disease Models, Animal; D006614:Hindlimb / Q000000981:diagnostic imaging; D016173:Macrophage Colony-Stimulating Factor / Q000494:pharmacology; D009154:Mutation / Q000235:genetics; D010010:Osteoclasts / Q000166:cytology / Q000378:metabolism; D010022:Osteopetrosis / Q000097:blood* / Q000235:genetics / Q000473:pathology; D011859:Radiography; D051381:Rats; D011922:Rats, Mutant Strains; D013154:Spleen / Q000166:cytology; D013977:Tibia / Q000648:ultrastructure
chemical_list: D016173:Macrophage Colony-Stimulating Factor; D002117:Calcitriol